Understanding brain changes in Alzheimer's disease using a new rat model
Consequences of noradrenergic degeneration in the novel TgF344-AD rat model
This research explores how early brain changes in Alzheimer's disease affect memory and learning, using a special rat model that closely mimics human disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11334369 on NIH RePORTER |
What this research studies
Our brains have a special area called the locus coeruleus, which sends an important chemical called noradrenaline to other parts of the brain, including the hippocampus, crucial for memory. In Alzheimer's disease, this locus coeruleus is often one of the first areas to show damage, leading to a loss of noradrenaline. This project uses a unique rat model that develops similar brain changes to those seen in human Alzheimer's. By studying these rats, we hope to better understand how the loss of noradrenaline impacts memory and learning, and how these changes contribute to the disease.
Who could benefit from this research
Good fit: This foundational research uses an animal model, so it does not directly involve human participants at this stage, but future clinical applications may benefit individuals with early Alzheimer's disease or those at risk.
Not a fit: Patients not affected by Alzheimer's disease or related memory conditions would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to a better understanding of early Alzheimer's disease and help identify new targets for treatments that could protect memory.
How similar studies have performed: Previous research has highlighted the importance of noradrenaline in memory, but current animal models have not fully captured the early brain damage seen in human Alzheimer's, making this new rat model a novel approach.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Mcmahon, Lori Lynn — University of Virginia
- Study coordinator: Mcmahon, Lori Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.